©The Author(s) 2025.
World J Clin Pediatr. Dec 9, 2025; 14(4): 113328
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.113328
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.113328
Table 9 Cross-tabulation of Na levels between the studied groups, n (%)
| Interventional (n = 70) | Control (n = 70) | P value | |
| On day 2 | |||
| Hyponatremia on day 2 | 38 (54.3) | 34 (48.5) | 0.491 |
| Normal natremia on day 2 | 32 (45.7) | 36 (51.4) | |
| On day 4 | |||
| Hyponatremia on day 4 | 37 (52.8) | 35 (50) | 0.731 |
| Normal natremia on day 4 | 33 (47.2) | 35 (50) | |
| On discharge | |||
| Hyponatremia on discharge | 21 (30) | 39 (55.7) | 0.021,a |
| Normal natremia on discharge | 49 (70) | 31 (44.3) | |
- Citation: Atef Abdelsattar Ibrahim H, Agha M, Taha M. Effects of oral rehydration solution-based prophylactic sodium supplementation on clinical outcomes in pediatric pneumonia: A randomized controlled trial. World J Clin Pediatr 2025; 14(4): 113328
- URL: https://www.wjgnet.com/2219-2808/full/v14/i4/113328.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v14.i4.113328